Cited by 14Physical Activity and HealthMobile Health and mHealth ApplicationsContext-Aware Activity Recognition Systems

Effectiveness of wearable technology‐based physical activity interventions for adults with type 2 diabetes mellitus: A systematic review and meta‐regression

Open access
Chua, Rachael Ern Ching, Lau, Ying, Ang, Wen Wei, Boey, Allison Ann Ying Faustina, Lau, Siew Tiang·2024·Journal of Diabetes

Abstract

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with the increasing prevalence of a modern sedentary lifestyle. Wearable technology‐based physical activity interventions (WT‐BPAI) might provide a channel to improve diabetic self‐management. The study aimed to (1) evaluate the effectiveness of WT‐BPAI on PA levels, glycemic levels, and other outcomes (blood pressure [BP], body mass index [BMI], and serum lipid profile) in adults with T2DM, and (2) investigate the potential covariates affecting aforementioned outcomes. Eight databases were searched thoroughly using three steps from inception until January 16, 2024. The quality of the studies and overall evidence were evaluated. The package meta of the R software program version 4.3.1. was utilized for meta‐analyses, subgroup analyses, and meta‐regression analyses. A total of 19 randomized controlled trials (RCTs) were found. Meta‐analyses revealed that WT‐BPAI significantly increased 1583 steps per day and decreased systolic BP (SBP) by 2.46 mmHg. Subgroup and meta‐regression analyses found that function, duration of intervention, and age were significant covariates. According to the risk of bias version 2, more than half of the trials raised some concerns about the randomization process, deviations from the intended intervention, and missing outcome data. The certainty of the evidence was very low for all outcomes based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria. WT‐BPAI can be considered a supplementary intervention to increase the steps per day and decrease SBP, especially when used for short periods in young adults with T2DM. However, we need more well‐designed research with long‐term outcomes. image

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/1753-0407.70002

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Wearable device-related interventions improved BMI (moderate-quality evidence).

    “Two reviews [43, 45] indicated that wearable device‐related interventions improved BMI (moderate‐quality evidence) but had no significant effect on body weight (low‐quality evidence).”

    From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [45]

    The Results section (BP, BMI, and serum lipid profile) reports a significant but very small reduction in BMI effect size, while finding no significant difference in mean BMI between intervention and control groups. The Results section (Certainty of evidence and publication bias) rates the evidence for all outcomes as very low, not moderate. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Wearable activity trackers significantly increased daily step counts in patients with T2D (p < 0.05), with low evidence certainty.

    “Three reviews evaluated the effect of wearable activity trackers on daily step counts in patients with T2D [42, 43, 45], all reporting statistically significant increases in the intervention group (p < 0.05) but with low evidence certainty.”

    From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [45]

    The Results (Physical activity) report a significant increase of 1,583 steps per day with wearable-based interventions (p < 0.05). However, the Results (Certainty of evidence and publication bias) rate the evidence for all outcomes as very low under GRADE, rather than low. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Wearable device-based interventions reduced systolic blood pressure.

    “and one [45] reported reduced systolic blood pressure (both moderate‐quality evidence).”

    From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [45]

    The Results (BP, BMI, and serum lipid profile) report a significant reduction in systolic blood pressure with wearable interventions. However, the Results (Certainty of evidence and publication bias) rate all outcomes as very low-certainty evidence, not the moderate-quality evidence stated in the citing sentence. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Wearable device-related interventions had no significant effect on body weight (low-quality evidence).

    “Two reviews [43, 45] indicated that wearable device‐related interventions improved BMI (moderate‐quality evidence) but had no significant effect on body weight (low‐quality evidence).”

    From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [45]

    The Results (BP, BMI, and serum lipid profile; page unavailable) report no significant difference in mean BMI between intervention and control groups, but do not report a body-weight result. The Results (Certainty of evidence and publication bias; page unavailable) rate the evidence for all outcomes as very low, not low. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Pedometers and smart wristbands effectively increase daily step counts and physical activity levels, contributing to improvements in lipid profiles and blood pressure.

    “In exercise management, pedometers and smart wristbands effectively increase daily step counts and physical activity levels, contributing to improvements in lipid profiles and blood pressure [42–45].”

    From Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta‐Analyses (2026) · cites this paper as [45]

    The Results (Physical activity; page not supplied) report a significant increase of 1,583 steps per day, but not a significant increase in moderate-to-vigorous physical activity. The Discussion (Blood pressure) reports reduced systolic, but not diastolic, blood pressure. Contrary to the lipid-profile portion of the claim, the Discussion (Serum lipid profile) reports no significant lipid differences. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 80 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

  1. [4]International Diabetes Federation. Diabetes around the world in 2021. 2022. https://diabetesatlas.org/#:~:text=Diabetes%20around%20the%20world%20in%202021%3A,%2D%20and%20middle%2Dincome%20countries 35914061
  2. [25]McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV, Thomas J. Chapter 3: defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. www.training.cochrane.org/handbook
  3. [27]Lefebvre C, Glanville J, Briscoe S, et al. Chapter 4: searching for and selecting studies. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. www.training.cochrane.org/handbook
  4. [33]Li T, Higgins JPT, Deeks JJ. Chapter 5: collecting data. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane; 2023. www.training.cochrane.org/handbook
  5. [40]Deeks JJ, Higgins JPT, Altman DG. Chapter 10: analysing data and undertaking meta‐analyses. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; 2022.
  6. [45]Higgins JPT, Li T, Deeks JJ. Chapter 6: choosing effect measures and computing estimates of effect. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; 2022.
  7. [49]Schünemann HJ, Higgins JPT, Vist GE, et al. Chapter 14: completing ‘summary of findings’ tables and grading the certainty of the evidence. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; 2022.
  8. [59]Kempny A, Moczulski D, Kempny A. Pedometer improves doctor's advive to enhance physical activity in type 2 diabetes. Diabetol Dosw Klin. 2008; 8(1): 33‐ 37.
  9. [71]Eyth E, Naik R. Hemoglobin A1C. StatPearls Publishing; 2022. 31747223

Cited by

Sorted by citations

Authors
Chua, R. E. C., Lau, Y., Ang, W. W., Boey, A. A. Y. F., & Lau, S. T.
Affiliations
  • SingHealth (SG)
  • Chinese University of Hong Kong (HK)
  • National University of Singapore (SG)
Corresponding author
Lau, Ying
Venue
Journal of Diabetes
Publisher
Wiley
Published
2024-10
Volume
16
Issue
10
Pages
e70002-e70002
ISSN
  • 1753-0393 (ISSN-L)
  • 1753-0407
OpenAlex
W4403134747
Cited by
14
References
80
Citations by year
2026: 11 · 2025: 3
FWCI
0.80
Type
journal article
Language
en
Open access
Locations
  • Journal of Diabetes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Context-Aware Activity Recognition Systems
Keywords
type 2 diabetes, wearable devices, physical activity interventions, step count, glycemic control, systolic blood pressure, body mass index, lipid profile, diabetes self-management, intervention duration, young adults
MeSH terms
Wearable Electronic Devices, Adult, Blood Pressure, Diabetes Mellitus, Type 2, Exercise Therapy, Humans, Exercise, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review